| #31 |
Heinz Pauls |
Aventis Pharmaceuticals |
1 |
| #31 |
Joey John Michalchuk |
Thomson Licensing |
1 |
| #31 |
Ronald P. Rohrbach |
Honeywell |
1 |
| #31 |
Robert Eugene Frahm |
— |
1 |
| #31 |
James Harold Atherton |
Sarnoff |
1 |
| #31 |
Lea Ann Conway |
Johnson & Johnson |
1 |
| #31 |
Kenneth DeRosa |
Kx Technologies |
1 |
| #31 |
Robert D. Carvelli |
AT&T |
1 |
| #31 |
Cynthia Ray |
Anthrogenesis |
1 |
| #31 |
Dwayne. Lee Looney |
Johnson & Johnson |
1 |
| #31 |
Sherry Collier |
H. Lundbeck A/S |
1 |
| #31 |
Eugenia Y. Kiselgof |
Schering |
1 |
| #31 |
Steven A. Middleton |
Johnson & Johnson |
1 |
| #31 |
Mallikarjun Sundaram |
Momenta Pharmaceuticals |
1 |
| #31 |
Bahman Barazesh |
Agere Systems |
1 |
| #31 |
Robert Segarich |
ExxonMobil |
1 |
| #31 |
Melton B. Affrime |
Schering |
1 |
| #31 |
Kevin Cooper |
Agency For Science, Technology And Research |
1 |
| #31 |
Maud Urbanski |
Johnson & Johnson |
1 |
| #31 |
Muthiah Thiyagarajan |
Az Electronic Materials (Luxembourg) S.A.R.L. |
1 |
| #31 |
Harold D. Ochs |
Mcneil-Ppc |
1 |
| #31 |
Steven Polston |
AT&T |
1 |
| #31 |
Sean C. Ely |
Ingersoll-Rand |
1 |
| #31 |
Douglas James Riexinger |
Bristol-Myers Squibb |
1 |
| #31 |
Pavel Kortunov |
ExxonMobil |
1 |
| #31 |
Donald Joergens |
— |
1 |